Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells

被引:20
|
作者
Li, Deguan [1 ,2 ]
Chen, Renxiang [3 ]
Wang, Yi-Wen [3 ]
Fornace, Albert J., Jr. [3 ,4 ]
Li, Heng-Hong [3 ,4 ]
机构
[1] Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China
[2] Peking Union Med Coll, Tianjin, Peoples R China
[3] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA
[4] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA
基金
中国国家自然科学基金;
关键词
Programmed cell death protein 1 (PD-1); ionizing radiation; T cells; checkpoint blockade; ANTITUMOR IMMUNITY; UP-REGULATION; RADIATION; CANCER; MICROENVIRONMENT; ACTIVATION; RESISTANCE; RESPONSES; EXPOSURE; OVERCOME;
D O I
10.1080/09553002.2017.1400192
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: In this study we addressed the question whether radiation-induced adverse effects on T cell activation are associated with alterations of T cell checkpoint receptors. Materials and methods: Expression levels of checkpoint receptors on T cell subpopulations were analyzed at multiple post-radiation time points ranging from one to four weeks in mice receiving a single fraction of 1 or 4 Gy of c-ray. T cell activation associated metabolic changes were assessed. Results: Our results showed that prior irradiation resulted in significant elevated expression of programmed cell death protein 1 (PD-1) in both CD4+ and CD8+ populations, at all three post-radiation time points. T cells with elevated PD-1 mostly were either central memory or naive cells. In addition, the feedback induction of PD-1 expression in activated T cells declined after radiation. Conclusion: Taken together, the elevated PD-1 level observed at weeks after radiation exposure is connected to T cell dysfunction. Recent preclinical and clinical studies have showed that a combination of radiotherapy and T cell checkpoint blockade immunotherapy including targeting the programmed death-ligand 1 (PD-L1)/PD-1 axis may potentiate the antitumor response. Understanding the dynamic changes in PD-1 levels in T cells after radiation should help in the development of a more effective therapeutic strategy.
引用
收藏
页码:488 / 494
页数:7
相关论文
共 50 条
  • [21] Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment
    Jomrich, Gerd
    Kollmann, Dagmar
    Ramazanova, Dariga
    Ristl, Robin
    Grose, Richard P.
    Ilhan-Mutlu, Ayseguel
    Preusser, Matthias
    Fassnacht, Christina
    Tsai, Yi-Chien
    Guenova, Emmanuella
    Schoppmann, Sebastian F.
    EJSO, 2022, 48 (02): : 383 - 390
  • [22] Programmed death receptor 1 (PD-1) ligand Fc fusion proteins reduce T-cell proliferation in vitro independently of PD-1
    Biemond, Melissa
    Vremec, David
    Gray, Daniel H. D.
    Hodgkin, Philip D.
    Heinzel, Susanne
    IMMUNOLOGY AND CELL BIOLOGY, 2024, 102 (02): : 117 - 130
  • [23] Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma
    Dorfman, DM
    Brown, JA
    Shahsafaei, A
    Freeman, GJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (07) : 802 - 810
  • [24] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [25] Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study
    Le Cesne, A.
    Marec-Berard, P.
    Blay, J. -Y.
    Gaspar, N.
    Bertucci, F.
    Penel, N.
    Bompas, E.
    Cousin, S.
    Toulmonde, M.
    Bessede, A.
    Fridman, W. H.
    Sautes-Fridman, C.
    Kind, M.
    Le Loarer, F.
    Pulido, M.
    Italiano, A.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : 151 - 157
  • [26] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [27] PROGRAMMED CELL DEATH PROTEIN (PD-1) BLOCKADE IN ADVANCED AND METASTATIC SQUAMOUS CELL CARCINOMA OF THE SKIN
    Vaidya, P.
    Lin, S.
    In, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 : A196 - A196
  • [28] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Matsuda, Kotaro
    Miyoshi, Hiroaki
    Hiraoka, Koji
    Hamada, Tetsuya
    Yoshida, Shiro
    Ishibashi, Yukinao
    Haraguchi, Toshiaki
    Shiba, Naoto
    Ohshima, Koichi
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 487 - 494
  • [29] The Role of Programmed Cell Death 1/Programmed Death Ligand 1 (PD-1/PD-L1) Axis in Sepsis-Induced Apoptosis
    Coman, Oana
    Grigorescu, Bianca-Liana
    Hutanu, Adina
    Bacarea, Anca
    Vasiesiu, Anca Meda
    Fodor, Raluca Stefania
    Stoica, Florin
    Azamfirei, Leonard
    MEDICINA-LITHUANIA, 2024, 60 (07):
  • [30] Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade
    Osorio, Juan C.
    Arbour, Kathryn C.
    Le, Dung T.
    Durham, Jennifer N.
    Plodkowski, Andrew J.
    Halpenny, Darragh F.
    Ginsberg, Michelle S.
    Sawan, Peter
    Crompton, Joseph G.
    Yu, Helena A.
    Namakydoust, Azadeh
    Nabet, Barzin Y.
    Chaft, Jamie E.
    Riely, Gregory J.
    Rizvi, Hira
    Diaz, Luis A., Jr.
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (36) : 3546 - +